Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?
Identifieur interne : 000267 ( PubMed/Curation ); précédent : 000266; suivant : 000268Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?
Auteurs : Azar Hadadi [Iran] ; Masoud Mortezazadeh [Iran] ; Kasra Kolahdouzan [Iran] ; Golbarg Alavian [Iran]Source :
- Journal of medical virology [ 1096-9071 ] ; 2020.
Abstract
An 80-year-old man with multiple comorbidities presented to the emergency department with tachypnea, tachycardia, fever and critically low O2 saturation and definitive chest CT scan findings in favor of COVID-19 and positive PCR results in 48 h. He received antiviral treatment plus recombinant human Erythropoietin(rhEPO) due to his severe anemia. After 7 days of treatment, he was discharged with miraculous improvement in his symptoms and hemoglobin level. We concluded that rhEPO could attenuate respiratory distress syndrome and confront the SARS-CoV-2 virus through multiple mechanisms including cytokine modulation, anti-apoptotic effects, leukocyte release from bone marrow, and iron redistribution away from the intracellular virus. This article is protected by copyright. All rights reserved.
DOI: 10.1002/jmv.25839
PubMed: 32270515
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000267
Links to Exploration step
pubmed:32270515Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?</title>
<author><name sortKey="Hadadi, Azar" sort="Hadadi, Azar" uniqKey="Hadadi A" first="Azar" last="Hadadi">Azar Hadadi</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Infectious Diseases, Sina Hospital, Tehran University of Medical Sciences, Tehran</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mortezazadeh, Masoud" sort="Mortezazadeh, Masoud" uniqKey="Mortezazadeh M" first="Masoud" last="Mortezazadeh">Masoud Mortezazadeh</name>
<affiliation wicri:level="1"><nlm:affiliation>Internal Medicine Department, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Internal Medicine Department, Sina Hospital, Tehran University of Medical Sciences, Tehran</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kolahdouzan, Kasra" sort="Kolahdouzan, Kasra" uniqKey="Kolahdouzan K" first="Kasra" last="Kolahdouzan">Kasra Kolahdouzan</name>
<affiliation wicri:level="1"><nlm:affiliation>Cancer Institute, Radiation Oncology Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Cancer Institute, Radiation Oncology Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Alavian, Golbarg" sort="Alavian, Golbarg" uniqKey="Alavian G" first="Golbarg" last="Alavian">Golbarg Alavian</name>
<affiliation wicri:level="1"><nlm:affiliation>Pharmacotherapy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Pharmacotherapy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32270515</idno>
<idno type="pmid">32270515</idno>
<idno type="doi">10.1002/jmv.25839</idno>
<idno type="wicri:Area/PubMed/Corpus">000267</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000267</idno>
<idno type="wicri:Area/PubMed/Curation">000267</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000267</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?</title>
<author><name sortKey="Hadadi, Azar" sort="Hadadi, Azar" uniqKey="Hadadi A" first="Azar" last="Hadadi">Azar Hadadi</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Infectious Diseases, Sina Hospital, Tehran University of Medical Sciences, Tehran</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mortezazadeh, Masoud" sort="Mortezazadeh, Masoud" uniqKey="Mortezazadeh M" first="Masoud" last="Mortezazadeh">Masoud Mortezazadeh</name>
<affiliation wicri:level="1"><nlm:affiliation>Internal Medicine Department, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Internal Medicine Department, Sina Hospital, Tehran University of Medical Sciences, Tehran</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kolahdouzan, Kasra" sort="Kolahdouzan, Kasra" uniqKey="Kolahdouzan K" first="Kasra" last="Kolahdouzan">Kasra Kolahdouzan</name>
<affiliation wicri:level="1"><nlm:affiliation>Cancer Institute, Radiation Oncology Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Cancer Institute, Radiation Oncology Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Alavian, Golbarg" sort="Alavian, Golbarg" uniqKey="Alavian G" first="Golbarg" last="Alavian">Golbarg Alavian</name>
<affiliation wicri:level="1"><nlm:affiliation>Pharmacotherapy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Pharmacotherapy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of medical virology</title>
<idno type="eISSN">1096-9071</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">An 80-year-old man with multiple comorbidities presented to the emergency department with tachypnea, tachycardia, fever and critically low O2 saturation and definitive chest CT scan findings in favor of COVID-19 and positive PCR results in 48 h. He received antiviral treatment plus recombinant human Erythropoietin(rhEPO) due to his severe anemia. After 7 days of treatment, he was discharged with miraculous improvement in his symptoms and hemoglobin level. We concluded that rhEPO could attenuate respiratory distress syndrome and confront the SARS-CoV-2 virus through multiple mechanisms including cytokine modulation, anti-apoptotic effects, leukocyte release from bone marrow, and iron redistribution away from the intracellular virus. This article is protected by copyright. All rights reserved.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32270515</PMID>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year>
<Month>Apr</Month>
<Day>08</Day>
</PubDate>
</JournalIssue>
<Title>Journal of medical virology</Title>
<ISOAbbreviation>J. Med. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.25839</ELocationID>
<Abstract><AbstractText>An 80-year-old man with multiple comorbidities presented to the emergency department with tachypnea, tachycardia, fever and critically low O2 saturation and definitive chest CT scan findings in favor of COVID-19 and positive PCR results in 48 h. He received antiviral treatment plus recombinant human Erythropoietin(rhEPO) due to his severe anemia. After 7 days of treatment, he was discharged with miraculous improvement in his symptoms and hemoglobin level. We concluded that rhEPO could attenuate respiratory distress syndrome and confront the SARS-CoV-2 virus through multiple mechanisms including cytokine modulation, anti-apoptotic effects, leukocyte release from bone marrow, and iron redistribution away from the intracellular virus. This article is protected by copyright. All rights reserved.</AbstractText>
<CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hadadi</LastName>
<ForeName>Azar</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Infectious Diseases, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mortezazadeh</LastName>
<ForeName>Masoud</ForeName>
<Initials>M</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0003-3585-9379</Identifier>
<AffiliationInfo><Affiliation>Internal Medicine Department, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kolahdouzan</LastName>
<ForeName>Kasra</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Cancer Institute, Radiation Oncology Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Alavian</LastName>
<ForeName>Golbarg</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Pharmacotherapy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Med Virol</MedlineTA>
<NlmUniqueID>7705876</NlmUniqueID>
<ISSNLinking>0146-6615</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute Respiratory Distress Syndrome</Keyword>
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">Cytokine</Keyword>
<Keyword MajorTopicYN="N">Erythropoietin</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>4</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>4</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>4</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32270515</ArticleId>
<ArticleId IdType="doi">10.1002/jmv.25839</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000267 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000267 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:32270515 |texte= Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:32270515" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |